Ellagic acid and its fermentative derivative urolithin A show reverse effects on the gp91-phox gene expression, resulting in opposite alterations in all-trans retinoic acid-induced superoxide generating activity of U937 cells

Ellagitannins (esters composed of glucose and ellagic acid) are hydrolyzed to generate ellagic acid in gut followed by conversion of ellagic acid to urolithins such as urolithin A by intestinal bacteria. Since urolithins are absorbed by gut easier than ellagitannins and ellagic acid, and show various physiological activities (e.g. anticancer, anti-cardiovascular disease, anti-diabetes mellitus, anti-obesity and anti-Alzheimer disease activities), they are expected as excellent health-promoting phytochemicals. Here, using human monoblast U937 cells, we investigated the effect of ellagic acid and urolithin A on the superoxide anion (O-2(-))-generating system of phagocytes, which is consisted of five specific protein factors (membrane proteins: p22-phox and gp91-phox, cytosolic proteins: p40-phox, p47-phox and p67-phox). Twenty micromolar of urolithin A enhanced the all-trans retinoic acid (ATRA)-induced O-2(-)-generating activity (to similar to 175%) while 20 mu M ellagic acid inhibited the ATRA-induced O-2(-)-generating activity (to similar to 70%). Semiquantitative RT-PCR showed that transcription level of gp91-phox was certainly decreased (to similar to 70%) in ATRA plus ellagic acid-treated cells, while that of gp91-phox was significantly increased (to similar to 160%) in ATRA plus urolithin A-treated cells. Chromatin immunoprecipitation assay suggested that urolithin A enhanced acetylations of Lys-9 residues of histone H3 within chromatin surrounding the promoter region of gp91-phox gene, but ellagic acid suppressed the acetylations. Immunoblotting also revealed that ATRA plus urolithin A-treatment up-regulated protein levels of p22-phox (to similar to 160%) and gp91-phox (to similar to 170%) although ATRA plus ellagic acid-treatment down-regulated protein levels of p22-phox (to similar to 70%) and gp91-phox (to similar to 60%). These results suggested that conversion of ellagic acid to urolithin A in gut may bring about reverse effects on the gp91-phox gene expression, resulting in opposite alterations in O-2(-) generating activity of intestinal macrophages.

Automated summary

The conversion of ellagic acid to urolithin A in the gut may have opposite effects on the expression of the gp91-phox gene in intestinal macrophages, resulting in contrasting alterations in O-2(-) generating activity.